OneSource and BRL ink technology licensing agreement to deliver high-concentration biologics subcutaneously
Revolutionary technology will further boost OneSource’s scientific services offerings
Revolutionary technology will further boost OneSource’s scientific services offerings
Sapala has a strong customer base including innovator Pharma, CDMOs & diagnostic companies
The newly issued patent, US Patent No. 11,957,647, provides both expanded scope of protection as well as longer patent term
Pharma Solutions operates 10 research and development and/or production sites globally
The acquisition of Healint aligns with Aptar Digital Health’s strategy to broaden its portfolio in neurology and strengthen its global footprint for digital health deployment
Commercialization of rPEG lipids designed to improve immunogenicity profile for nucleic acid delivery
According to Sun Pharma, the purpose of the strategic investment is to obtain access to the technology for certain compounds and territories while also fostering the development of novel pharmaceutical delivery systems.
New facility is part of Aptar Pharma’s global expansion program
PhytoSquene now available for clinical and commercial use
Subscribe To Our Newsletter & Stay Updated